Regencell Bioscience Holdings Stock Alpha and Beta Analysis
| RGC Stock | USD 45.00 14.23 46.25% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Regencell Bioscience Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Regencell Bioscience over a specified time horizon. Remember, high Regencell Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Regencell Bioscience's market risk premium analysis include:
Beta (5.88) | Alpha 5.12 | Risk 32.88 | Sharpe Ratio 0.19 | Expected Return 6.33 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Regencell |
Regencell Bioscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Regencell Bioscience market risk premium is the additional return an investor will receive from holding Regencell Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Regencell Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Regencell Bioscience's performance over market.| α | 5.12 | β | -5.88 |
Regencell Bioscience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Regencell Bioscience's Buy-and-hold return. Our buy-and-hold chart shows how Regencell Bioscience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Regencell Bioscience Market Price Analysis
Market price analysis indicators help investors to evaluate how Regencell Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regencell Bioscience shares will generate the highest return on investment. By understating and applying Regencell Bioscience stock market price indicators, traders can identify Regencell Bioscience position entry and exit signals to maximize returns.
Regencell Bioscience Return and Market Media
The median price of Regencell Bioscience for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 is 4.8 with a coefficient of variation of 109.75. The daily time series for the period is distributed with a sample standard deviation of 7.01, arithmetic mean of 6.39, and mean deviation of 3.46. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Bell Thomas D Jr of 25000 shares of Regencell Bioscience at 14.76 subject to Rule 16b-3 | 12/20/2024 |
2 | Acquisition by Ownby David of 19416 shares of Regencell Bioscience subject to Rule 16b-3 | 01/17/2025 |
3 | Regal Cineworld To Bring Barco Laser Projection To 4000 Screens By 2030 | 01/29/2025 |
4 | How Is Regal Rexnord Navigating Changing Market Conditions | 02/13/2025 |
5 | Vontobel Holding Ltd. Sells 5,260 Shares of Regal Rexnord Co. | 02/14/2025 |
6 | Heres Why Were Not Too Worried About Regencell Bioscience Holdings Cash Burn Situation | 02/21/2025 |
7 | Full Year 2024 Regal Partners Ltd Earnings Call Transcript | 02/26/2025 |
8 | Buick Regal Gets An Update In China, Adds Sporty GS | 03/03/2025 |
9 | Acquisition by Yemenidjian Alex of 4977 shares of Regencell Bioscience at 22.1 subject to Rule 16b-3 | 03/07/2025 |
10 | Market Cool On Regal Partners Limiteds Revenues Pushing Shares 27 percent Lower | 03/13/2025 |
11 | Why Regencell Bioscience Holdings Limited Soared Last Week | 03/17/2025 |
12 | Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday | 03/20/2025 |
About Regencell Bioscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Regencell or other stocks. Alpha measures the amount that position in Regencell Bioscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | |
| Effective Tax Rate | 0.55 | 0.35 |
| Operating Profit Margin | 0.0988 | 0.12 |
Regencell Bioscience Upcoming Company Events
As portrayed in its financial statements, the presentation of Regencell Bioscience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Regencell Bioscience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Regencell Bioscience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Regencell Bioscience. Please utilize our Beneish M Score to check the likelihood of Regencell Bioscience's management manipulating its earnings.
| 26th of January 2024 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Build Portfolio with Regencell Bioscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Regencell Bioscience Backtesting, Regencell Bioscience Valuation, Regencell Bioscience Correlation, Regencell Bioscience Hype Analysis, Regencell Bioscience Volatility, Regencell Bioscience History and analyze Regencell Bioscience Performance. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Regencell Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.